Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
An efficient synthesis of indolo[2,3-b]quinoline guanidine derivatives with their in vitro and in vivo study.
Med Chem Res. 2017;26(12):3354-3366. doi: 10.1007/s00044-017-2028-1. Epub 2017 Sep 5.
Med Chem Res. 2017.
PMID: 29170613
Free PMC article.
AD-O53.2--a novel recombinant fusion protein combining the activities of TRAIL/Apo2L and Smac/Diablo, overcomes resistance of human cancer cells to TRAIL/Apo2L.
Pieczykolan JS, Kubiński K, Masłyk M, Pawlak SD, Pieczykolan A, Rózga PK, Szymanik M, Gałązka M, Teska-Kamińska M, Żerek B, Bukato K, Poleszak K, Jaworski A, Strożek W, Świder R, Zieliński R.
Pieczykolan JS, et al. Among authors: zerek b.
Invest New Drugs. 2014 Dec;32(6):1155-66. doi: 10.1007/s10637-014-0153-y. Epub 2014 Sep 4.
Invest New Drugs. 2014.
PMID: 25182378
Item in Clipboard
Novel engineered TRAIL-based chimeric protein strongly inhibits tumor growth and bypasses TRAIL resistance.
Rozga P, Kloska D, Pawlak S, Teska-Kaminska M, Galazka M, Bukato K, Pieczykolan A, Jaworski A, Molga-Kaczmarska A, Kopacz A, Badyra B, Kachamakova-Trojanowska N, Zolnierkiewicz O, Targosz-Korecka M, Poleszak K, Szymanik M, Zerek B, Pieczykolan J, Jozkowicz A, Grochot-Przeczek A.
Rozga P, et al. Among authors: zerek b.
Int J Cancer. 2020 Aug 15;147(4):1117-1130. doi: 10.1002/ijc.32845. Epub 2020 Jan 24.
Int J Cancer. 2020.
PMID: 31863596
Free article.
Item in Clipboard
Improved cytotoxicity of novel TRAIL variants produced as recombinant fusion proteins.
Figiel M, Bonarek P, Górecki A, Pawlak SD, Zerek B, Checinska B, Pieczykolan J, Dziedzicka-Wasylewska M.
Figiel M, et al. Among authors: zerek b.
Protein Eng Des Sel. 2018 Feb 1;31(2):37-46. doi: 10.1093/protein/gzx065.
Protein Eng Des Sel. 2018.
PMID: 29361050
Item in Clipboard
Activity and rational combinations of a novel, engineered chimeric, TRAIL-based ligand in diffuse large B-cell lymphoma.
Piechna K, Żołyniak A, Jabłońska E, Noyszewska-Kania M, Szydłowski M, Żerek B, Kulecka M, Rumieńczyk I, Mikula M, Juszczyński P.
Piechna K, et al. Among authors: zerek b.
Front Oncol. 2022 Oct 31;12:1048741. doi: 10.3389/fonc.2022.1048741. eCollection 2022.
Front Oncol. 2022.
PMID: 36387080
Free PMC article.
Item in Clipboard
Cite
Cite